COMET

(redirected from Carvedilol or Metoprolol European Trial)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Cardiology Carvedilol or Metoprolol European Trial. A trial comparing carvedilol and immediate release metoprolol tartrate on clinical outcome in patients with moderate to severe heart failure
Conclusion Cardiovascular deaths occurred in 29% of carvedilol patients and in 35% of metoprolol patients
ENT Combined microscopic & endoscopic technique. An alternative to the technically demanding endoscopic sinus surgery for chronic sinus diseases, a technique which allows less experienced operators to manage these diseases with fewer complications
References in periodicals archive ?
In the Carvedilol or Metoprolol European Trial (COMET) 3,029 patients with heart failure were randomized to receive either carvedilol or immediate-release metolprolol tartrate.
The Carvedilol or Metoprolol European Trial (COMET) enrolled 3,029 patients with moderate to severe heart failure from 341 centers in 15 European countries.
In the Carvedilol or Metoprolol European Trial (COMET), (1) patients with heart failure were randomized to receive either carvedilol or metoprolol in addition to their current diuretic and angiotensin-converting enzyme inhibitor.